CliffBio
small molecule

ZEGALOGUE

DASIGLUCAGON HYDROCHLORIDE

Loss of exclusivityMarch 2035latest FDA-listed patent expiry
CompanyZealand Pharma →View the full company profile on CliffBio

Drug detail

Brand nameZEGALOGUE
Active ingredientDASIGLUCAGON HYDROCHLORIDE
StrengthEQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML)
Dosage formSOLUTION
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalMarch 2021
Marketing statusDISCN

Listed patents

PatentExpiresType
10442847March 2035substance, product
11795204January 2034use U-3752

Regulatory exclusivity

CodeExpires
NCEMarch 2026

More from Zealand Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ZEGALOGUE patent cliff — loss of exclusivity March 2035 | CliffBio